Suppr超能文献

注射亲代淋巴细胞后F1杂种对骨髓移植的抗性丧失。亲代抗F1 T杀伤细胞的证实及宿主中的全身免疫抑制。

Loss of F1 hybrid resistance to bone marrow grafts after injection of parental lymphocytes. Demonstration of parental anti-F1 T killer cells and general immunosuppression in the host.

作者信息

Knobloch C, Dennert G

机构信息

University of Southern California, Comprehensive Cancer Center, Los Angeles 90033.

出版信息

Transplantation. 1988 Jan;45(1):175-83. doi: 10.1097/00007890-198801000-00037.

Abstract

B6D2F1 mice acutely reject parental C57Bl/6 bone marrow grafts, a phenomenon that is known as hybrid resistance. Injection of C57Bl/6 splenocytes into B6D2F1 recipients prior to bone marrow transplantation had previously been shown to facilitate growth of C57Bl/6 marrow grafts. We show in this report that for this effect to occur, radiation-sensitive T cells have to be present in the splenocyte inoculum. Loss of hybrid resistance following injection of C57Bl/6 splenocytes into B6D2F1 mice coincides with the appearance of T killer cells of C57Bl/6 origin that are specific for H-2 histocompatibility antigens of DBA/2. The parental T killer cells in unresponsive B6D2F1 mice express in vitro cytotoxic activity on H-2d targets and appear to be responsible for the acquired in vivo rejection of H-2d bone marrow grafts. Appearance of donor-derived T killer cells coincides with marked suppression of host immunity: lymphocytes from unresponsive B6D2F1 mice do not proliferate in mixed lymphocyte reactions and fail to respond to sheep erythrocytes in vitro, nor do they express natural killer (NK) activity. Concomitant with the suppression of NK activity, hybrid resistance to C57B1/6 marrow grafts disappears. This loss of resistance to bone marrow transplants is unspecific since third-party SJL marrow grafts are not rejected. It is concluded that suppression of hybrid resistance by injection of parental splenocytes into B6D2F1 mice is caused by a severe nonspecific suppression of host immune responsiveness by parental T cells that recognize disparate histocompatibility antigens in the host.

摘要

B6D2F1小鼠会急性排斥亲代C57Bl/6骨髓移植,这种现象被称为杂种抗性。先前已表明,在骨髓移植前将C57Bl/6脾细胞注射到B6D2F1受体中可促进C57Bl/6骨髓移植的生长。我们在本报告中表明,为了产生这种效果,脾细胞接种物中必须存在辐射敏感的T细胞。将C57Bl/6脾细胞注射到B6D2F1小鼠后杂种抗性的丧失与源自C57Bl/6的T杀伤细胞的出现相吻合,这些T杀伤细胞对DBA/2的H-2组织相容性抗原有特异性。无反应的B6D2F1小鼠中的亲代T杀伤细胞在体外对H-2d靶标表现出细胞毒性活性,似乎是导致体内获得性排斥H-2d骨髓移植的原因。供体来源的T杀伤细胞的出现与宿主免疫的明显抑制相吻合:来自无反应的B6D2F1小鼠的淋巴细胞在混合淋巴细胞反应中不增殖,在体外对绵羊红细胞无反应,也不表达自然杀伤(NK)活性。与NK活性的抑制同时发生的是,对C57B1/6骨髓移植的杂种抗性消失。对骨髓移植抗性的这种丧失是非特异性的,因为第三方SJL骨髓移植不会被排斥。得出的结论是,将亲代脾细胞注射到B6D2F1小鼠中导致杂种抗性的抑制是由亲代T细胞对宿主中不同组织相容性抗原的识别导致的宿主免疫反应性的严重非特异性抑制引起的。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验